Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA molecular typing

E L Milford1

  • 1Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.

Current Opinion in Nephrology and Hypertension
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

DNA-based human leukocyte antigen (HLA) typing is replacing serology for more accurate organ transplant matching. This molecular HLA testing improves graft survival and is essential for bone marrow transplants.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial experience of dual maintenance immunosuppression with steroid withdrawal in vascular composite tissue allotransplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

TIRC7 and HLA-DR axis contributes to inflammation in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2014
Same author

Classifying antibodies using flow cytometry data: class prediction and class discovery.

Biometrical journal. Biometrische Zeitschrift·2006
Same author

Detecting antibodies with similar reactivity patterns in the HLDA8 blind panel of flow cytometry data.

Journal of immunological methods·2005
Same author

Soluble HLA-II expression in African-Americans.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2002
Same author

Molecular identification using flow cytometry histograms and information theory.

Proceedings. AMIA Symposium·2002
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
Same journal

Advancing science and care in CKD-MBD: the layered path to legacy.

Current opinion in nephrology and hypertension·2026
See all related articles

Area of Science:

  • Immunogenetics
  • Transplantation Science

Background:

  • Human leukocyte antigen (HLA) antigens are key barriers in organ transplantation.
  • HLA-A, -B, and -DR heterodimers significantly contribute to organ rejection.
  • Classical serology is being superseded by advanced molecular methods in histocompatibility testing.

Purpose of the Study:

  • To highlight the shift from serological to DNA-based HLA typing methods.
  • To emphasize the impact of molecular HLA typing on transplantation outcomes.
  • To discuss the current and future applications of molecular HLA testing in clinical settings.

Main Methods:

  • Review of established and evolving DNA-based HLA genotyping techniques.
  • Comparison of molecular methods with traditional serological phenotyping.

Related Experiment Videos

  • Analysis of HLA matching data in solid organ and bone marrow transplantation.

    • Main Results:

    • Molecular HLA typing offers greater accuracy than serology.
    • Improved correlation between HLA matching and graft survival is anticipated.
    • Molecular HLA testing is becoming standard in bone marrow transplantation for preventing graft-versus-host disease.

    Conclusions:

    • DNA-based HLA typing represents a significant advancement in transplantation.
    • Widespread adoption of molecular HLA methods will enhance transplant success rates.
    • Mandatory molecular HLA testing is crucial for high-risk transplantations like bone marrow procedures.